| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |